Log in


  • Home
  • Novel Developments in the Diagnosis and Treatment of Esophageal Cancer

Novel Developments in the Diagnosis and Treatment of Esophageal Cancer

  • 23 Jan 2014
  • 8:30 AM - 9:30 AM
  • Webinar


Registration is closed

To view a video introduction of the webinar from Prof. J.J.B. van Lanschot, please click here.

The following issues will be covered:

  • Epidemiology of esophageal cancer with marked differences between East and West;
  • Impact of alcohol, smoking, long standing reflux and obesity;
  • Substantial improvement of treatment outcome over last two decades;
  • Role of early detection (e.g. Barrett surveillance);
  • State-of-the-art pretreatment diagnostic work-up (esp. role of PET scanning);
  • Optimal surgical therapy (transhiatal vs transthoracic approach; role of MIE);
  • Importance of adequate lymph node dissection;
  • Impact of centralization and standardization of care;
  • Role of neoadjuvant chemotherapy versus chemoradiotherapy;
  • Response assessment after neoadjuvant therapy;
  • Indications for definitive chemoradiation;
  • Central role for multidisciplinary teams;
  • Main targets for further improvements.


Jan van Lanschot, MD, PhD
Professor of Surgery
Erasmus Medical Center
Rotterdam, the Netherlands

Convert to your time zone

Affiliated Societies

International  Interdisciplinary  Everything Esophageal

The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software